{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:54:32Z","timestamp":1788274472829,"version":"build-2803163510"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006679","name":"Kobayashi Magobe Memorial Medical Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006679","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Inokashira Hospital"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0234864","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T18:08:06Z","timestamp":1592503686000},"page":"e0234864","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)"],"prefix":"10.1371","volume":"15","author":[{"given":"Kohei","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminari","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-7036","authenticated-orcid":true,"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-4786","authenticated-orcid":true,"given":"Hiroyoshi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"issue":"8","key":"pone.0234864.ref001","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1176\/appi.ajp.158.8.1305","article-title":"A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia","volume":"158","author":"JM Azorin","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"4","key":"pone.0234864.ref002","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","article-title":"Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials","volume":"158","author":"M Chakos","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"4","key":"pone.0234864.ref003","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/schbul\/sbj067","article-title":"Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia","volume":"32","author":"SW Lewis","year":"2006","journal-title":"Schizophr Bull"},{"issue":"4","key":"pone.0234864.ref004","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"JP McEvoy","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"2","key":"pone.0234864.ref005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1017\/S1092852912000806","article-title":"Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses","volume":"18","author":"JS Souza","year":"2013","journal-title":"CNS Spectr"},{"issue":"9","key":"pone.0234864.ref006","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"J Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"pone.0234864.ref007","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: a review of clinical practice guidelines and prescribing trends","volume":"14","author":"S Warnez","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"2","key":"pone.0234864.ref008","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/JCP.0b013e31828700c7","article-title":"Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study","volume":"33","author":"C-C Lin","year":"2013","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"pone.0234864.ref009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/JCP.0b013e31827a813b","article-title":"Schizophrenia past clozapine: what works?","volume":"33","author":"FA Mustafa","year":"2013","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"pone.0234864.ref010","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1176\/ps.47.12.1382","article-title":"Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone","volume":"47","author":"DJ Still","year":"1996","journal-title":"Psychiatr Serv Wash DC"},{"issue":"Suppl","key":"pone.0234864.ref011","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1007\/BF00442571","article-title":"Adverse effects of clozapine","volume":"99","author":"R Grohmann","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl","key":"pone.0234864.ref012","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/BF00442565","article-title":"Clozapine in the treatment of 121 out-patients","volume":"99","author":"M Leppig","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"issue":"17","key":"pone.0234864.ref013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1192\/S0007125000296931","article-title":"Clinical management of clozapine patients in relation to efficacy and side-effects","author":"D Naber","year":"1992","journal-title":"Br J Psychiatry Suppl"},{"issue":"Suppl","key":"pone.0234864.ref014","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1007\/BF00442564","article-title":"Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia\u2014a retrospective study of 387 patients","volume":"99","author":"D Naber","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"pone.0234864.ref015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/oxfordjournals.schbul.a033333","article-title":"Management of the adverse effects of clozapine","volume":"24","author":"CR Young","year":"1998","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"pone.0234864.ref016","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.schres.2016.05.002","article-title":"Reasons for discontinuing clozapine: A cohort study of patients commencing treatment","volume":"174","author":"SE Legge","year":"2016","journal-title":"Schizophr Res"},{"issue":"3","key":"pone.0234864.ref017","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0269881107087976","article-title":"A new self-rating scale for detecting atypical or second-generation antipsychotic side effects","volume":"22","author":"L Waddell","year":"2008","journal-title":"J Psychopharmacol Oxf Engl"},{"issue":"1\u20132","key":"pone.0234864.ref018","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.schres.2015.07.052","article-title":"Glasgow Antipsychotic Side-effects Scale for Clozapine\u2014Development and validation of a clozapine-specific side-effects scale","volume":"168","author":"C Hynes","year":"2015","journal-title":"Schizophr Res"},{"issue":"1","key":"pone.0234864.ref019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"CJ Bachmann","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"pone.0234864.ref020","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organization","year":"1992"},{"key":"pone.0234864.ref021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpsychires.2016.06.005","article-title":"A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD)","volume":"80","author":"H Takeuchi","year":"2016","journal-title":"J Psychiatr Res"},{"key":"pone.0234864.ref022","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","article-title":"Making sense of Cronbach\u2019s alpha","volume":"2","author":"M Tavakol","year":"2011","journal-title":"Int J Med Educ"},{"issue":"1","key":"pone.0234864.ref023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"JR Landis","year":"1977","journal-title":"Biometrics"},{"key":"pone.0234864.ref024","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.psychres.2016.07.055","article-title":"Reliability of a patient-reported outcome measure in schizophrenia: Results from back-to-back self-ratings","volume":"244","author":"H Takeuchi","year":"2016","journal-title":"Psychiatry Res"},{"issue":"4","key":"pone.0234864.ref025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study","volume":"19","author":"LB Mokkink","year":"2010","journal-title":"Qual Life Res"},{"issue":"3","key":"pone.0234864.ref026","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0278-5846(94)90010-8","article-title":"The side-effects of clozapine: a four year follow-up study","volume":"18","author":"D Marinkovic","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0234864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T18:08:29Z","timestamp":1592503709000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0234864"}},"subtitle":[],"editor":[{"given":"Kazutaka","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0234864","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]}}}